Dapsone
- TRADE NAMES: Aczone (Allergan); Avlosulfon; Dapson; Dapson-Fatol; Maloprim; Protogen; Sulfona
- INDICATIONS: Leprosy, dermatitis herpetiformis, acne
- CLASS: Antibiotic, Antimicrobial, Antimycobacterial (including antitubercular)
- HALF-LIFE: 10–50 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Atovaquone/Proguanil, Chloroquine, Didanosine, Furazolidone, Ganciclovir, Hydroxychloroquine, Methotrexate, Pyrimethamine, Rifabutin, Rifampin, Rifapentine, Sulfonamides, Trimethoprim, Ursodiol
PREGNANCY CATEGORY: C
A hypersensitivity reaction – termed the 'sulfone syndrome' or 'dapsone syndrome' – may infrequently develop during the first six weeks of treatment. This syndrome consists of exfoliative dermatitis, fever, malaise, nausea, anorexia, hepatitis, jaundice, lymphadenopathy and hemolytic anemia.
Please login to see the rest of this drug profile
SKIN.
NAILS.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RENAL.
RESPIRATORY.
OTHER.
Page last updated 10/07/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric